Skip to content

Vitamin D Metabolites as Biomarkers for the Identification of Kidney Injury in Cardiac Surgery

Vitamin D Metabolites as Biomarkers for the Identification of Kidney Injury in Cardiac Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06688994
Acronym
VITAL
Enrollment
46
Registered
2024-11-14
Start date
2024-12-02
Completion date
2026-12-31
Last updated
2026-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Kidney Injuries, Chronic Renal Diseases

Keywords

Chronic renal disease, Acute kidney injury, Vitamin D

Brief summary

The investigators will be measuring vitamin D metabolites in blood samples drawn from patients undergoing cardiac surgery to determine the correlation with renal function as assessed by serum creatinine. The investigators will include 20 patients in each of the following 3 groups based on serum creatinine measured within 28-days of surgery: 1) normal kidney function (eGFR \> 60 mL/min, n=20), 2) moderate impaired kidney function, eGFR between 30 and 60 mL/min (n=20) and 3) severe kidney dysfunction eGFR \< 30 mL/min (n=20).

Interventions

None listed

Sponsors

University Health Network, Toronto
Lead SponsorOTHER
University of Toronto
CollaboratorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years * Patients undergoing cardiac surgery * Serum Creatinine measured with 28 days of surgery

Exclusion criteria

* Exogeneous calcitriol (1,25(OH)2D3) intake * History of parathyroidectomy * Patients with liver or kidney cancer * Patients with liver disease (e.g. liver failure, cirrhosis)

Design outcomes

Primary

MeasureTime frameDescription
Determine the correlation between eGFR as determined serum creatinine and vitamin D metabolites as markers of kidney functionUp to 1 month before surgery up until POD 7serum creatinine (sCr) and vitamin D metabolites (specifically 25(OH)D3 and 1,25(OH)2D3) will be measured in the same blood sample to determine the incidence of AKI and CKD in patients undergoing cardiac surgery

Countries

Canada

Contacts

PRINCIPAL_INVESTIGATORStuart A McCluskey, MD, PhD

University Health Network, Toronto

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026